About
Contact & Profiles
A5087317558
Research Areas
- Cardiac Arrest and Resuscitation
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Liver Disease and Transplantation
- Digital Imaging in Medicine
- Heart Rate Variability and Autonomic Control
- Renal Transplantation Outcomes and Treatments
- Lipoproteins and Cardiovascular Health
- Cardiac Ischemia and Reperfusion
- Organ Donation and Transplantation
- Chemotherapy-related skin toxicity
- Organ Transplantation Techniques and Outcomes
University of Utah
2023-2024
Cardiogenic shock (CS) mortality remains near 40%. In addition to inadequate cardiac output, patients with severe CS may exhibit vasodilation. We aimed examine the prevalence and consequences of vasodilation in CS.
10.1161/circheartfailure.124.011827
article
EN
Circulation Heart Failure
2024-07-25
10.1016/s0735-1097(25)04152-x
article
EN
Journal of the American College of Cardiology
2025-03-30
10.1016/j.healun.2025.02.450
article
EN
The Journal of Heart and Lung Transplantation
2025-04-01
We describe a novel use of evolocumab for successful postoperative lipid control in patient with familial hyperlipidemia who underwent isolated heart transplantation. believe that this case carries valuable lessons regarding post-transplant proprotein convertase subtilisin kexin 9 inhibitor implications the future combined organ allocation and transplantation waitlist times.
10.1016/j.jaccas.2024.102426
article
EN
cc-by-nc-nd
JACC Case Reports
2024-08-01
10.1016/j.healun.2023.02.1668
article
EN
The Journal of Heart and Lung Transplantation
2023-04-01
10.1016/j.healun.2023.02.439
article
EN
The Journal of Heart and Lung Transplantation
2023-04-01
Coming Soon ...